Horizon Funds - Horizon Flexible Income ETF
US ˙ BATS ˙ US33938J1060

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Ross A Md Jaffe. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Ross A Md Jaffe har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:UTRS / Minerva Surgical, Inc. Director 49.792
US:FLXN / Horizon Funds - Horizon Flexible Income ETF 10% Owner 20.739
US:GKOS / Glaukos Corporation 496
US:PZRX / PhaseRx, Inc. 10% Owner 1.931.094
US:INGN / Inogen, Inc. 10% Owner 55.345
US:EYES / Vivani Medical Inc 10% Owner 4.370.964
US:PODD / Insulet Corporation Director 55.461
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Ross A Md Jaffe. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb FLXN / Horizon Funds - Horizon Flexible Income ETF – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2016-06-08 FLXN Versant Ventures III, LLC 710.091 14,0000 710.091 14,0000 9.941.274 292 29.2600 10.835.989 109,00
2016-06-08 FLXN Versant Ventures III, LLC 4.194 14,0000 4.194 14,0000 58.716

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insidersalg FLXN / Horizon Funds - Horizon Flexible Income ETF – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

FLXN / Horizon Funds - Horizon Flexible Income ETF Insider Trades
Insiderkøb GKOS / Glaukos Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GKOS / Glaukos Corporation Insider Trades
Insidersalg GKOS / Glaukos Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2016-05-31 GKOS VERSANT VENTURES I LLC 10.970 23,9800 10.970 23,9800 263.061 1 24.3200 3.730 1,42
2016-05-31 GKOS VERSANT VENTURES I LLC 23.088 23,9800 23.088 23,9800 553.650

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

GKOS / Glaukos Corporation Insider Trades
Insiderkøb INGN / Inogen, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INGN / Inogen, Inc. Insider Trades
Insidersalg INGN / Inogen, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2014-11-17 INGN Versant Ventures II LLC 5.343 24,8852 5.343 24,8852 132.962 15 23.9200 -5.156 -3,88
2014-11-14 INGN Versant Ventures II LLC 3.928 25,0627 3.928 25,0627 98.446
2014-11-13 INGN Versant Ventures II LLC 5.505 25,1814 5.505 25,1814 138.624
2014-11-10 INGN Versant Ventures II LLC 2.992 24,4201 2.992 24,4201 73.065
2014-10-24 INGN Versant Ventures II LLC 4.647 20,7565 4.647 20,7565 96.455
2014-10-09 INGN Versant Ventures II LLC 1.756 20,8255 1.756 20,8255 36.570
2014-10-09 INGN Versant Ventures II LLC 144 20,8255 144 20,8255 2.999
2014-10-08 INGN Versant Ventures II LLC 6.382 21,0266 6.382 21,0266 134.192
2014-10-08 INGN Versant Ventures II LLC 525 21,0266 525 21,0266 11.039
2014-09-09 INGN Versant Ventures II LLC 7.388 23,2496 7.388 23,2496 171.768

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

INGN / Inogen, Inc. Insider Trades
Insiderkøb UTRS / Minerva Surgical, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

UTRS / Minerva Surgical, Inc. Insider Trades
Insidersalg UTRS / Minerva Surgical, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

UTRS / Minerva Surgical, Inc. Insider Trades
Insiderkøb VANI / Vivani Medical, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i FLXN / Horizon Funds - Horizon Flexible Income ETF. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VANI / Vivani Medical, Inc. Insider Trades
Insidersalg VANI / Vivani Medical, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i FLXN / Horizon Funds - Horizon Flexible Income ETF. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

VANI / Vivani Medical, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Ross A Md Jaffe som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2022-06-14 2022-06-10 4 UTRS MINERVA SURGICAL INC
Common Stock
A - Award 49.792 49.792 2,41 119.999 119.999
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -24.760 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -34.986 24.760 -58,56
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -35.009 59.746 -36,95
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 24.760 94.755 35,37
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 34.986 69.995 99,93
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 35.009 35.009
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -279.942 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -395.557 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -395.814 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 94.755 94.755
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -464 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -432 464 -48,21
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -438 896 -32,83
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -455 1.334 -25,43
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -73.816 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -68.634 73.816 -48,18
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -69.613 142.450 -32,83
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -72.374 212.063 -25,44
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 464 1.789 35,02
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 432 1.325 48,38
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 438 893 96,26
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 455 455
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 73.816 284.437 35,05
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 68.634 210.621 48,34
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 69.613 141.987 96,19
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 72.374 72.374
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -5.257 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -4.888 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -4.958 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -5.155 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -834.568 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -775.986 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -787.050 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -818.269 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -3.148 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -499.843 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series C Preferred Stock
C - Conversion -5.536 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series C Preferred Stock
C - Conversion -878.947 0 -100,00
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 10.473 10.473
2022-02-10 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 1.663.227 1.663.227
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -24.760 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -34.986 24.760 -58,56
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -35.009 59.746 -36,95
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 24.760 94.755 35,37
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 34.986 69.995 99,93
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 35.009 35.009
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -279.942 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -395.557 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -395.814 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 94.755 94.755
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -464 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -432 464 -48,21
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -438 896 -32,83
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -455 1.334 -25,43
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -73.816 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -68.634 73.816 -48,18
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -69.613 142.450 -32,83
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -72.374 212.063 -25,44
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 464 1.789 35,02
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 432 1.325 48,38
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 438 893 96,26
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 455 455
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 73.816 284.437 35,05
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 68.634 210.621 48,34
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 69.613 141.987 96,19
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 72.374 72.374
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -5.257 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -4.888 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -4.958 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -5.155 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -834.568 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -775.986 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -787.050 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion -818.269 0 -100,00
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 1.789 1.789
2021-12-08 2021-10-26 4/A UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 284.437 284.437
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion 0
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -24.760 0 -100,00
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -34.986 24.760 -58,56
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion -35.009 59.746 -36,95
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 24.760 94.755 35,37
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 34.986 69.995 99,93
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Series D Preferred Stock
C - Conversion 35.009 35.009
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion 0
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Subordinated Secured Convertible Promissory Note
C - Conversion 0
2021-10-28 2021-10-26 4 UTRS MINERVA SURGICAL INC
Common Stock
C - Conversion 94.755 94.755
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 4.194 20.739 25,35 14,00 58.716 290.346
2016-06-10 2016-06-08 4 FLXN Flexion Therapeutics Inc
Common Stock
P - Purchase 710.091 3.511.670 25,35 14,00 9.941.274 49.163.380
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 496 496
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 2.317 2.317
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 397 397
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 397 397
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 989 989
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 989 989
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 741 741
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other 128.758 128.758
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
S - Sale -23.088 109.395 -17,43 23,98 -553.650 2.623.292
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
S - Sale -10.970 51.247 -17,63 23,98 -263.061 1.228.903
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other -9.892 46.804 -17,45
2016-06-02 2016-05-31 4 GKOS GLAUKOS Corp
Common Stock
J - Other -505.297 2.379.539 -17,52
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 596.477 1.931.094 44,69 5,00 2.982.385 9.655.470
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -182.914 1.334.617 -12,05 0,01 -1.829 13.346
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -73.615 1.517.531 -4,63 0,01 -736 15.175
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
P - Purchase 3.523 11.408 44,68 5,00 17.615 57.040
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -1.080 7.885 -12,05 0,01 -11 79
2016-05-24 2016-05-23 4 PZRX PHASERX, INC.
Common Stock
S - Sale -435 8.965 -4,63 0,01 -4 90
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
1.553.618
2016-05-17 3 PZRX PHASERX, INC.
Common Stock
3.080.023
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -552 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -1.296 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -577 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock Warrant (right to buy)
M - Exercise -27.612 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -5.465 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -12.840 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -5.715 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series F Convertible Preferred Stock
C - Conversion -273.337 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -3.271 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -7.684 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -3.420 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series E Convertible Preferred Stock
C - Conversion -163.592 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -10.791 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -25.226 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -11.805 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series D Convertible Preferred Stock
C - Conversion -548.464 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -9.386 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -21.900 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -10.428 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series C Convertible Preferred Stock
C - Conversion -479.714 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -16.666 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -38.888 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -18.518 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series B Convertible Preferred Stock
C - Conversion -851.852 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -10.800 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -25.200 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -12.000 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Series A Convertible Preferred Stock
C - Conversion -552.000 0 -100,00
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -235 56.696 -0,41 18,00 -4.230 1.020.528
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 552 56.931 0,98
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 56.379 56.379
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -551 132.483 -0,41 18,00 -9.918 2.384.694
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 1.296 133.034 0,98
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 131.738 131.738
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -246 62.217 -0,39 18,00 -4.428 1.119.906
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 577 62.463 0,93
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 61.886 61.886
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
F - Taxes -11.736 2.884.835 -0,41 18,00 -211.248 51.927.030
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
M - Exercise 27.612 2.896.571 0,96
2015-06-30 2015-06-30 4 GKOS GLAUKOS Corp
Common Stock
C - Conversion 2.868.959 2.868.959
2015-05-11 2014-11-07 4/A INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2015-05-11 2014-11-06 4/A INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 1.398 4.572 44,05
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 486 3.174 18,08
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.596 15.180 58,39
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 388 9.584 4,22
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 5.594 14.789 60,84
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 194 9.195 2,16
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -42.216 0 -100,00
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other 42.216 42.216
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -389.136 2.917.544 -11,77
2015-05-11 2014-11-05 4/A INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 4.459 16.329 37,57
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 56.385 46,25
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 87.719 25,52
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 87.461 25,61
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other 17.832 85.497 26,35
2015-01-08 2015-01-07 4 INGN Inogen Inc
Common Stock
J - Other -136.039 0 -100,00
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 972 17.301 5,95
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 56.871 0,86
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 486 88.205 0,55
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 389 56.516 0,69
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 778 54.941 1,44
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other 136.039 136.039
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -778.272 1.263.716 -38,11
2015-01-08 2015-01-06 4 INGN Inogen Inc
Common Stock
J - Other -6.952 7.812 -47,09
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 607 11.870 5,39
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.986 11.263 21,41
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 244 38.295 0,64
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.942 38.051 26,38
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 488 36.331 1,36
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 7.950 35.843 28,50
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2015-01-05 2014-12-18 4/A INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 607 11.870 5,39
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.986 11.263 21,41
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 305 38.553 0,80
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.944 38.248 26,21
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 244 38.295 0,64
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.942 38.051 26,38
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 488 36.331 1,36
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 7.950 35.843 28,50
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -60.344 0 -100,00
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 1.126 60.344 1,90
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other 59.218 59.218
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -486.420 2.041.988 -19,24
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -4.345 14.764 -22,74
2014-12-22 2014-12-18 4 INGN Inogen Inc
Common Stock
J - Other -9.235 31.334 -22,76
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.370.964
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
82.949
2014-12-02 3/A EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
39.062
2014-11-19 2014-11-17 4 INGN Inogen Inc
Common Stock
S - Sale -5.343 40.569 -11,64 24,89 -132.962 1.009.568
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
8.862.939
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.574.924
2014-11-18 3 EYES SECOND SIGHT MEDICAL PRODUCTS INC
Common Stock
4.530.037
2014-11-14 2014-11-14 4 INGN Inogen Inc
Common Stock
S - Sale -3.928 45.912 -7,88 25,06 -98.446 1.150.679
2014-11-14 2014-11-13 4 INGN Inogen Inc
Common Stock
S - Sale -5.505 49.840 -9,95 25,18 -138.624 1.255.041
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 972 9.277 11,70
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 3.733 8.305 81,65
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 30.304 1,63
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 486 30.304 1,63
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.929 29.818 100,27
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 388 30.109 1,31
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 14.932 29.721 100,97
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 776 27.893 2,86
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -113.112 0 -100,00
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other 113.112 113.112
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -778.272 2.528.408 -23,54
2014-11-14 2014-11-12 4 INGN Inogen Inc
Common Stock
J - Other -6.952 19.109 -26,68
2014-11-12 2014-11-10 4 INGN Inogen Inc
Common Stock
S - Sale -2.992 12.188 -19,71 24,42 -73.065 297.632
2014-11-07 2014-11-07 4 INGN Inogen Inc
Common Stock
S - Sale -3.150 55.345 -5,39 23,95 -75.442 1.325.507
2014-11-07 2014-11-06 4 INGN Inogen Inc
Common Stock
S - Sale -4.238 58.495 -6,76 24,56 -104.092 1.436.737
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 1.398 4.572 44,05
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 486 3.174 18,08
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.595 14.889 60,20
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 9.294 2,68
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.595 3.321.569 0,17
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 243 3.315.974 0,01
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.596 15.180 58,39
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 388 9.584 4,22
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 5.594 14.789 60,84
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other 194 9.195 2,16
2014-11-07 2014-11-05 4 INGN Inogen Inc
Common Stock
J - Other -3.476 26.061 -11,77
2014-10-28 2014-10-24 4 INGN Inogen Inc
Common Stock
S - Sale -4.647 0 -100,00 20,76 -96.455
2014-10-14 2014-10-09 4 INGN Inogen Inc
Common Stock
S - Sale -144 0 -100,00 20,83 -2.999
2014-10-14 2014-10-09 4 INGN Inogen Inc
Common Stock
S - Sale -1.756 0 -100,00 20,83 -36.570
2014-10-09 2014-10-08 4 INGN Inogen Inc
Common Stock
S - Sale -525 144 -78,48 21,03 -11.039 3.028
2014-10-09 2014-10-08 4 INGN Inogen Inc
Common Stock
S - Sale -6.382 1.756 -78,42 21,03 -134.192 36.923
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 669 669
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.138 8.138
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 2.202 2.688 453,09
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.808 9.051 3.624,69
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.808 9.051 3.624,69
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.808 3.408.001 0,26
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other 8.807 9.001 4.539,69
2014-10-09 2014-10-07 4 INGN Inogen Inc
Common Stock
J - Other -66.857 0 -100,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Stock Option (right to buy)
X - Other -2.250 6.750 -25,00
2014-09-12 2014-09-10 4 FLXN Flexion Therapeutics Inc
Common Stock
X - Other 2.250 2.250 17,61 39.622 39.622
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 486 486
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 243 243
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 388 388
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other 194 194
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other -389.136 3.306.680 -10,53
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
J - Other -3.476 29.537 -10,53
2014-09-12 2014-09-09 4 INGN Inogen Inc
Common Stock
S - Sale -7.388 62.733 -10,54 23,25 -171.768 1.458.517
2012-02-22 2012-02-22 4 PODD INSULET CORP
Common Stock
S - Sale -12.193 55.461 -18,02 19,78 -241.182 1.097.041
2012-02-22 2012-02-22 4 PODD INSULET CORP
Common Stock
S - Sale -5.807 26.409 -18,03 19,78 -114.872 522.415
2012-02-22 2012-02-21 4 PODD INSULET CORP
Common Stock
S - Sale -10.297 67.654 -13,21 19,96 -205.545 1.350.482
2012-02-22 2012-02-21 4 PODD INSULET CORP
Common Stock
S - Sale -4.903 32.216 -13,21 19,96 -97.872 643.083
2012-02-22 2012-02-17 4 PODD INSULET CORP
Common Stock
S - Sale -4.827 77.951 -5,83 20,38 -98.368 1.588.548
2012-02-22 2012-02-17 4 PODD INSULET CORP
Common Stock
S - Sale -2.298 37.119 -5,83 20,38 -46.830 756.441
2012-02-21 2012-02-16 4 "PODD" INSULET CORP
Common Stock
J - Other 18.520 18.520
2012-02-21 2012-02-16 4 "PODD" INSULET CORP
Common Stock
S - Sale -11.707 23.768 -33,00
2012-02-21 2012-02-16 4 "PODD" INSULET CORP
Common Stock
S - Sale -598.380 1.214.893 -33,00
2008-05-12 2008-05-08 4 PODD INSULET CORP
Stock Option (right to buy)
A - Award 3.810 3.810
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)